Agilon Health, Inc. (NYSE:AGL - Get Free Report) has earned a consensus recommendation of "Hold" from the eighteen brokerages that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $2.8077.
A number of analysts have issued reports on AGL shares. Weiss Ratings reiterated a "sell (e+)" rating on shares of Agilon Health in a research note on Wednesday, October 8th. Evercore ISI reduced their target price on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. Benchmark reduced their target price on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Barclays reduced their target price on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research note on Wednesday, August 6th. Finally, Wells Fargo & Company reduced their target price on shares of Agilon Health from $5.00 to $1.50 and set an "overweight" rating for the company in a research note on Tuesday, October 7th.
Read Our Latest Report on AGL
Institutional Trading of Agilon Health
Institutional investors and hedge funds have recently modified their holdings of the company. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new stake in shares of Agilon Health in the second quarter worth $31,000. 111 Capital acquired a new stake in shares of Agilon Health in the second quarter worth $36,000. Nisa Investment Advisors LLC lifted its stake in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares during the last quarter. Acropolis Investment Management LLC acquired a new stake in shares of Agilon Health in the second quarter worth $44,000. Finally, Gabelli Funds LLC acquired a new stake in shares of Agilon Health in the first quarter worth $48,000.
Agilon Health Stock Performance
Shares of AGL opened at $0.99 on Tuesday. The firm has a market cap of $408.62 million, a PE ratio of -1.28 and a beta of 0.07. The firm's 50 day moving average price is $1.12 and its 200 day moving average price is $2.21. Agilon Health has a twelve month low of $0.71 and a twelve month high of $6.08.
Agilon Health (NYSE:AGL - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. Agilon Health's revenue was down 5.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.07) earnings per share. On average, sell-side analysts anticipate that Agilon Health will post -0.59 earnings per share for the current fiscal year.
About Agilon Health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.